Epstein Secrets

uthern Trust Co. - Fixed Income (Morgan Stanley) Charles Schwab 8.0% Preferred 525 par 7/27/15 40,000 1

now called Adverum Biotechnologles 4/20/15 10,000 298.806 28,500 25,500 -373,106 BASF ADR 4/13/15 5000 508,056 486,430 472,250 -35.806 Bank of New York Mellon 6/25/14 250,000 9.076,406 11,765,000 11,780.000 2,703.594 Biogen Idec Inc 2/14/12 2,095 250,455 568,185 519,078 268,623 Bioverativ Inc

uthern Trust Co. - Fixed Income (Morgan Stanley) Charles Sthweb 6.0% Preferred 525par 7/27/15 40000 1,0

now called Adverum Blotechnologles 4/20/15 10,000 398,606 25 030 25500 -373.106 BASF ADR 4/13/15 5,000 508,056 466,450 476.350 -31,708 Bank of New York Mellon 6/25/14 250,000 12,755,000 0 Biogen Idec Inc 2114/12 2,095 250,455 568,499 606.691 356,236 Bioverativ Inc 2/1/17 1,047 20,254 62,998

uthern Trust Co. - Fixed income (Morgan Stanley) Charles Schwab 8.0% Preferred $25 par 727/15 40,000 1,

les now called Adverum Beledinolcoes 4120115 10000 398,606 25,000 25500 -373,108. BASF ADR 4/13/15 ‘000 508,056 466,450 476,350 -31,706 Bank of New York Mellon 6/25/14 250,000 9,076 406 12,755,000 - -9,076 408 Biogen Idec Inc 2/14/12 Z095 250,455 568,499 608.691 356,236 Bioverativ Inc 2/1/17

uthern Trutt CO. - Fixed Income (Morgan Stanley) Charles Schwab 6.0% Preferred 525 pat 7/27/15 40,000 1

s now called Advorum Btotochnolowes 4/20/16 10,000 398,606 25,000 25,500 373,106 BASF ADR 4/13/15 5,000 508.056 466,450 476,350 -31,706 Bank of New York Mellon 6/25/14 250.000 9.076.406 12,755,000 -9,076,406 356.236 Biogen Idec Inc 2114/12 2,095 250,455 568,499 606.691 Bioverativ Inc OM 1,047

uthern Trust Co. - Fixed Income (Morgan Stanley) Charles Schwab 6.0% Preferred $25 per 7/27/15 40,000 1

now called Adverum Biotechnologies 4/20/15 10.000 398,608 25,000 25,500 -373,106 BASF ADR 4/13/15 5,000 508,056 466,450 478,350 -31,706 Bank of New York Mellon 6/25/14 2561,000 12,755,000 - 0 Blogen Ides Inc 2/14/12 2.095 250.455 568,499 606,691 356238 Bioverativ Inc 2/1/17 1,047 20,254 62,9

uthern Trust Co. - Fixed Income (Morgan Stanley) Charles Schwab 6.0% Preferred $25 par 7/27/15 40.000 1

s now called Adverum Biotechnologies 4/20/15 10 000 398,606 25500 25,000 -373 606 -41,606 BASF ADR 4/13/15 5000 508,056 472,250 486,450 Bank of New York Mellon 6/25/14 2517,000 9,076,406 11,780,000 12,755,000 3,678594 318.044 Blogen Idec Inc 2/14/12 2,095 250.455 519.078 568,499 Bioverativ Inc

uthern Trust Co. - Fixed Income (Morgan Stanley) Charles Schwab 6.0% Preferred $25 per 7/27/15 40,000 1

now called Adverum Biotechnologies 4/20/15 10.000 398,608 25,000 25,500 -373,106 BASF ADR 4/13/15 5,000 508,056 466,450 478,350 -31,706 Bank of New York Mellon 6/25/14 2561,000 12,755,000 - 0 Blogen Ides Inc 2/14/12 2.095 250.455 568,499 606,691 356238 Bioverativ Inc 2/1/17 1,047 20,254 62,9

uthern Trutt CO. - Fixed Income (Morgan Stanley) Charles Schwab 6.0% Preferred 525 pat 7/27/15 40,000 1

s now called Advorum Btotochnolowes 4/20/16 10,000 398,606 25,000 25,500 373,106 BASF ADR 4/13/15 5,000 508.056 466,450 476,350 -31,706 Bank of New York Mellon 6/25/14 250.000 9.076.406 12,755,000 -9,076,406 356.236 Biogen Idec Inc 2114/12 2,095 250,455 568,499 606.691 Bioverativ Inc OM 1,047